Literature DB >> 11128893

The relation of serum leptin to body mass index and to serum cortisol in men with spinal cord injury.

T S Huang1, Y H Wang, S Y Chen.   

Abstract

OBJECTIVE: To investigate the relations among serum leptin, body mass index (BMI), and various hormone levels in men with spinal cord injury (SCI).
DESIGN: Cross-sectional.
SETTING: University hospital that is a tertiary referral center. PARTICIPANTS: Forty-seven men with traumatic neurologically complete SCI and 47 age- and BMI-matched male controls. MAIN OUTCOME MEASURES: Baseline levels of various hormones were measured in subjects with SCI. Serum leptin and cortisol levels and BMI were measured in both groups.
RESULTS: Serum leptin was significantly higher in the group with SCI than in the control group. A linear relation was found between serum leptin and BMI in both groups separately. A polynomial relation was found between serum leptin level and BMI in the group with SCI. A "J" phenomenon is noted at the lowest BMI. Serum cortisol correlated significantly with serum leptin level in the group with SCI.
CONCLUSION: Sympathetic denervation, peripheral nerve palsy, recurrent infections, and possible central neurotransmitter alterations after SCI may contribute to the elevation of serum leptin level in men with SCI.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11128893     DOI: 10.1053/apmr.2000.9173

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  18 in total

Review 1.  An evidence-based review of aging of the body systems following spinal cord injury.

Authors:  S L Hitzig; J J Eng; W C Miller; B M Sakakibara
Journal:  Spinal Cord       Date:  2010-12-14       Impact factor: 2.772

2.  C-reactive protein as an available biomarker determining mental component of health-related quality of life among individuals with spinal cord injury.

Authors:  Hadis Sabour; Sahar Latifi; Zahra Soltani; Hania Shakeri; Abbas Norouzi Javidan; Seyed-Mohammad Ghodsi; Mohammad Reza Hadian; Seyed-Hassan Emami Razavi
Journal:  J Spinal Cord Med       Date:  2016-02-25       Impact factor: 1.985

Review 3.  Leptin and brain-adipose crosstalks.

Authors:  Alexandre Caron; Syann Lee; Joel K Elmquist; Laurent Gautron
Journal:  Nat Rev Neurosci       Date:  2018-02-16       Impact factor: 34.870

4.  Serum leptin levels following acute experimental spinal cord injury.

Authors:  Ali Riza Gezici; Ruchan Ergun; Alper Karakas; Bulent Gunduz
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

5.  Longitudinal change in FEV1 and FVC in chronic spinal cord injury.

Authors:  Kelly L Stolzmann; David R Gagnon; Robert Brown; Carlos G Tun; Eric Garshick
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

6.  Omega-3 fatty acids' effect on leptin and adiponectin concentrations in patients with spinal cord injury: A double-blinded randomized clinical trial.

Authors:  Hadis Sabour; Abbas Norouzi Javidan; Sahar Latifi; Farzad Shidfar; Ramin Heshmat; Seyed-Hassan Emami Razavi; Mohammad Reza Vafa; Bagher Larijani
Journal:  J Spinal Cord Med       Date:  2014-08-06       Impact factor: 1.985

7.  Determinants of lung volumes in chronic spinal cord injury.

Authors:  Evan L Stepp; Robert Brown; Carlos G Tun; David R Gagnon; Nitin B Jain; Eric Garshick
Journal:  Arch Phys Med Rehabil       Date:  2008-08       Impact factor: 3.966

8.  Association of daily stressors and salivary cortisol in spinal cord injury.

Authors:  Claire Z Kalpakjian; Debra J Farrell; Kathie J Albright; Anthony Chiodo; Elizabeth A Young
Journal:  Rehabil Psychol       Date:  2009-08

Review 9.  Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies.

Authors:  Ricardo A Battaglino; Antonio A Lazzari; Eric Garshick; Leslie R Morse
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

10.  Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents.

Authors:  Grewo Lim; Shuxing Wang; Yi Zhang; Yinghong Tian; Jianren Mao
Journal:  J Clin Invest       Date:  2009-01-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.